Latest CanVECTOR News
August 24, 2016
The Network News August edition available now

Find it on the News & Events page!

Read More
Article Thumbnail
June 17, 2016
Dr. David Anderson interviewed by CTV on EPCAT II study

CanVECTOR member David Anderson was recently interviewed by CTV Atlantic about the EPCAT II study.

 

Read More

Annual incidence of

2/1000

population per year

Cost of VTE: at least

$600m

CAD a year

VTE recurrence

5-10%

per year

Chronic thromboembolic pulmonary hypertension

3-4%

after PE

Pulmonary Embolism
leads to the hospitalization
or death of over

30,000

Canadians every year

VTE leads to significant

long-term
costs

in the form of chronic complications of VTE

Post-thrombotic syndrome

20-40%

after DVT

Adverse effects and

burden of anticoagulant therapy

Upcoming Events

Thursday, October 13, 2016

World Thrombosis Day

Learn more about the campaign and how to participate here: http://www.worldthrombosisday.org/
Friday, October 14, 2016

12th Annual McMaster Update in Thromboembolism & Hemostasis

Target Audience Health Care Practitioners and Other Health Care Professionals dealing with patients with or at risk of venous thromboembolism with a special focus on primary care issues. Learning Ob...
Saturday, October 22, 2016
Duration: 4 days

Canadian Cardiovascular Congress 2016

The 2016 Canadian Cardiovascular Congress (CCC) is being held at the Palais des congrès in Montreal, Quebec from Saturday, October 22 to Tuesday, October 25, 2016. Year after year, CCC continu...

Evidence Pearls on VTE

Evidence Pearls on VTE RSS Feed
Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone.
Sep 30, 2016
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
Sep 30, 2016
Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.
Sep 30, 2016

Twitter